700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
Gene therapy is emerging out as an important trend in the pathophysiology and treatment of hypertension. Several gene targets have been identified in recent years. They include rennin, angiotensin converting enzyme, anglotensin receptors, kallikrein, endothelin, nitric oxide, adrenomedullin, glucocorticoid- suppressible hyperaldosteronism and several peptides including atrial natriuretic factor. Clinically, there are several problems before gene therapy is actually available. Once gene therapy becomes a reality, it will be a significant break through in the field of treatment of hypertension.
To read the full article Peer-reviewed Article PDF
Author(s): Rajeshri G Karki Anita A Mehta R K Goyal